JENNY DAUBERT: Open Payments
NPI 1548676778 · MARIETTA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$551 in 24 payments from 13 companies in 2025. Trend: 2023 $1,790 · 2024 $2,051 · 2025 $551
Food & beverage: $551
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $107 |
| Janssen Biotech, Inc. | 3 | $99 |
| Madrigal Pharmaceuticals | 1 | $64 |
| Ardelyx, Inc. | 3 | $60 |
| GENZYME CORPORATION | 2 | $39 |
| Celltrion USA Inc. | 2 | $37 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $30 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $27 |
| QOL Medical, LLC | 1 | $20 |
| Phathom Pharmaceuticals, Inc. | 1 | $19 |
Products named: TREMFYA, REZDIFFRA, IBSRELA, SKYRIZI, RINVOQ, DUPIXENT, VEGZELMA, XIFAXAN.
Industry payments across OH — which companies pay providers there.
